Bill116th CongressFiled Jan 30, 2019Health
H.R. 863
DXM Abuse Prevention Act of 2019
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jan 30, 2019)
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1)the sale of over-the-counter drugs containing DXM, and (2)the distribution of bulk DXM.
What just happenedJan 30, 2019
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Matsui, Doris O. [D-CA-6](D-CA)Sponsor
3 cosponsors2 D1 R
3cosponsors1committees3actions8subjects
- Introduced in HouseJan 30, 2019
- Jan 30, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 30, 2019IntroReferralIntro-H
Introduced in House
- Jan 30, 2019IntroReferral1000
Introduced in House